Mun, H.S.; Kim, S.H.; Lee, J.; Park, S.J.; Lee, A.; Kang, J.; Park, W.-C.; Bae, S.Y.; Choi, B.O.; Hong, J.H.;
et al. Skeletal Muscle Density as a Predictive Marker for Pathologic Complete Response in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemoimmunotherapy. Cancers 2025, 17, 1768.
https://doi.org/10.3390/cancers17111768
AMA Style
Mun HS, Kim SH, Lee J, Park SJ, Lee A, Kang J, Park W-C, Bae SY, Choi BO, Hong JH,
et al. Skeletal Muscle Density as a Predictive Marker for Pathologic Complete Response in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemoimmunotherapy. Cancers. 2025; 17(11):1768.
https://doi.org/10.3390/cancers17111768
Chicago/Turabian Style
Mun, Han Song, Sung Hun Kim, Jieun Lee, Se Jun Park, Ahwon Lee, Jun Kang, Woo-Chan Park, Soo Youn Bae, Byung Ok Choi, Ji Hyun Hong,
and et al. 2025. "Skeletal Muscle Density as a Predictive Marker for Pathologic Complete Response in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemoimmunotherapy" Cancers 17, no. 11: 1768.
https://doi.org/10.3390/cancers17111768
APA Style
Mun, H. S., Kim, S. H., Lee, J., Park, S. J., Lee, A., Kang, J., Park, W.-C., Bae, S. Y., Choi, B. O., Hong, J. H., Oh, S. N., & Shin, K.
(2025). Skeletal Muscle Density as a Predictive Marker for Pathologic Complete Response in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemoimmunotherapy. Cancers, 17(11), 1768.
https://doi.org/10.3390/cancers17111768
